Insider trade

Exascale Labs (XLAB): Director received 15K units

Shachar Kariv, Director at Exascale Labs, reported a grant / award of 15K units.

15K
Derivative units
Traded
Oct 6, 2026
Filed
Oct 6, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 27, 2026Company filing · Form 8-K · Material agreement, Agreement endedCompleted buying or selling a business or assets, and received a notice from its stock exchange (and 9 more items)“The information set forth in the Introductory Note of this Current Report on Form 8-K and in the section entitled “Information about Directors and Executive Officers” in Item 2.01 of this Current Report on Form 8-K is incorporated by reference herein.”
  2. Aug 27, 2026Company filing · Form 8-K · Acquisition or saleCompleted buying or selling a business or assets“The disclosures set forth in (i) the “ Introductory Note ” above and (ii) the “ Introductory Note ” and Item 1.01 of the Original Form 8-K are incorporated into this Item 2.01 by reference. 1 FORM 10 INFORMATION Item 2.01(f) of Form 8-K states that if the predecessor registrant was a shell company, as BCAR was immediately before the consummation of the Business Combination, then the registrant must disclose the…”
  3. Sep 4, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 4, 2026, Exascale Labs Holdings Inc. (the “Company”) appointed Gildas Bonnier as Interim Chief Financial Officer of the Company, effective as of September 4, 2026.”
  4. Sep 25, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“Effective September 25, 2026, Gildas Bonnier ceased serving as the Interim Chief Financial Officer of Exascale Labs Holdings Inc. (the “Company”). As previously reported, Mr. Bonnier was appointed as the Company’s Interim Chief Financial Officer while the Company conducted a formal search process to identify and appoint a permanent Chief Financial Officer of the Company.”
  5. Sep 28, 2026Company filing · Form 8-K · ResultsReported its results

What came next

  1. Oct 9, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
  2. Oct 15, 20265% stakeARC Group International Limited reported a passive stake (13G) of 14.7%
  3. Oct 29, 20265% stakeHack Seed Fund II LP reported a passive stake (13G) of 5.9%
  4. Nov 3, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Exascale Labs

For Exascale Labs, OQRO holds 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its XLAB page.

How this filing works

Explore the data

Common questions

Which Exascale Labs (XLAB) insider traded, and how much?

Shachar Kariv, Director at Exascale Labs, reported a grant / award of 15K units. Not an open-market trade.

When did it happen, and when was it made public?

Traded: Oct 6, 2026. Filed: Oct 6, 2026.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Exascale Labs recently?

For Exascale Labs, OQRO holds 2 fund holdings reports (13F) dated in the last 90 days. They are listed on the XLAB page.

Does this mean XLAB stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Exascale Labs

Everything OQRO holds on this company is on its XLAB page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data